# SSX5

## Overview
SSX5 is a gene that encodes the protein SSX family member 5, which is part of the cancer-testis antigen family. This protein is primarily expressed in the testis and is involved in transcriptional repression through its interaction with Polycomb group proteins, contributing to chromatin remodeling and gene expression regulation. SSX5 contains a KRAB domain, characteristic of transcriptional repressors, and a conserved SSXRD domain, which facilitates its nuclear localization and function. While the gene is typically silent in most somatic tissues, its aberrant expression is observed in various cancers, including synovial sarcomas and prostate cancer, where it may play a role in tumorigenesis and serve as a potential target for immunotherapy (Güre2002The; Simpson2005Cancertestis; Zöllner2015Synovial).

## Structure
The SSX5 protein is a member of the SSX gene family, characterized by a high degree of homology among its members, with protein homology ranging from 73% to 92% (Güre2002The). The SSX5 protein consists of 188 amino acids and contains several key structural features. It includes a KRAB domain at the N-terminal, which is involved in transcriptional repression (Güre2002The; dos2000Molecular). The protein is rich in charged amino acids and has an acidic C-terminal tail, which is a common feature among SSX family proteins (de2002The).

The SSX5 protein also contains the SSXRD domain, which is highly conserved within the SSX family and is responsible for nuclear localization and colocalization with Polycomb group proteins in nuclear speckles (dos2000Molecular). This domain is implicated in transcriptional repression by recruiting Polycomb group complexes to target genes (dos2000Molecular).

Alternative splicing has been observed in SSX genes, leading to variant transcripts that could result in proteins of different sizes, although the existence of these variant proteins in vivo is not confirmed (Güre2002The). The SSX5 protein lacks a DNA-binding domain but can repress transcription in transfected cells (de2002The).

## Function
SSX5, a member of the SSX gene family, is primarily expressed in the testis and is involved in transcriptional repression. The SSX5 protein is localized in the nucleus, where it acts as a transcriptional repressor by recruiting Polycomb group (PcG) proteins to target genes, which helps maintain the repressed state of these genes through chromatin structure modifications (Zöllner2015Synovial; dos2000Molecular). The SSX5 protein contains a KRAB domain, typical of Kruppel-like transcription factors, and a highly conserved SSXRD domain, which is crucial for its nuclear localization and function (Güre2002The; de2002The).

In healthy human cells, SSX5 expression is primarily detected in the testis, specifically in spermatogonia, and may be regulated by changes in methylation patterns (dos2000Molecular). The SSX proteins, including SSX5, are thought to play a role in chromatin remodeling and gene expression regulation, impacting cellular growth and development (Zöllner2015Synovial). Despite their involvement in transcriptional repression, the specific molecular processes and cellular roles of SSX5 in healthy human cells are not fully detailed in the available literature (Güre2002The).

## Clinical Significance
The SSX5 gene, a member of the cancer-testis antigen family, is implicated in various cancers due to its aberrant expression. SSX5 is typically expressed in the testis but is also found in several tumor types, including synovial sarcomas, where it is involved in the t(X;18) translocation (Güre2002The). Its expression is often induced in cancer cell lines through demethylation, a process associated with oncogenesis (Güre2002The). In hepatocellular carcinoma (HCC), SSX5 mRNA is detectable in the peripheral blood of a significant proportion of patients, suggesting its potential as a molecular marker for early diagnosis (Fawzy2014Expression).

In prostate cancer, SSX5 expression is primarily observed in metastatic lesions, indicating a role in disease progression and making it a potential target for immunotherapy (Smith2011Expression). The SSX family, including SSX5, is known for its immunogenic properties, which are being explored for cancer vaccine development (Simpson2005Cancertestis). The reactivation of SSX5 in somatic cells may contribute to tumorigenesis by conferring characteristics such as immortality and immune evasion (Simpson2005Cancertestis).

## Interactions
SSX5, a member of the SSX protein family, is known for its role in transcriptional repression and chromatin remodeling. SSX proteins, including SSX5, are characterized by their interaction with polycomb group proteins (PcG), such as HPC2, BMI1, and RING1/2. These interactions are crucial for modulating gene expression through chromatin remodeling. The interaction with BMI1 specifically requires an intact amino-terminal domain of SSX proteins (Zöllner2015Synovial).

While specific interactions of SSX5 are not detailed, the general interaction pattern of SSX proteins with PcG proteins is highlighted. SSX proteins are strong transcriptional repressors due to the presence of the KRAB domain, and they localize in the nucleus, where they exert their repressive functions (Zöllner2015Synovial).

In prostate cancer, SSX5 expression is inducible with treatment using a methylation inhibitor, suggesting that its expression is regulated by epigenetic factors such as DNA methylation. This inducibility indicates potential interactions with epigenetic modifying agents, although specific protein interactions in this context are not detailed (Smith2011Expression).


## References


[1. (Smith2011Expression) Heath A. Smith, Robert J. Cronk, Joshua M. Lang, and Douglas G. McNeel. Expression and immunotherapeutic targeting of the ssx family of cancer–testis antigens in prostate cancer. Cancer Research, 71(21):6785–6795, October 2011. URL: http://dx.doi.org/10.1158/0008-5472.CAN-11-2127, doi:10.1158/0008-5472.can-11-2127. This article has 69 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-11-2127)

[2. (de2002The) Diederik R.H. de Bruijn, Nuno R. dos Santos, Ellen Kater‐Baats, José Thijssen, Lieke van den Berk, Jiska Stap, Matthé Balemans, Marga Schepens, Gerard Merkx, and Ad Geurts van Kessel. The cancer‐related protein ssx2 interacts with the human homologue of a ras‐like gtpase interactor, rab3ip, and a novel nuclear protein, ssx2ip. Genes, Chromosomes and Cancer, 34(3):285–298, March 2002. URL: http://dx.doi.org/10.1002/gcc.10073, doi:10.1002/gcc.10073. This article has 47 citations.](https://doi.org/10.1002/gcc.10073)

[3. (dos2000Molecular) Nuno R. dos Santos, Diederik R.H. de Bruijn, and Ad Geurts van Kessel. Molecular mechanisms underlying human synovial sarcoma development. Genes, Chromosomes and Cancer, 30(1):1–14, 2000. URL: http://dx.doi.org/10.1002/1098-2264(2000)9999:9999<::aid-gcc1056>3.0.co;2-g, doi:10.1002/1098-2264(2000)9999:9999<::aid-gcc1056>3.0.co;2-g. This article has 195 citations.](https://doi.org/10.1002/1098-2264(2000)9999:9999)

[4. (Fawzy2014Expression) Amal Fawzy, Niveen Fawzy, Amr El-Sayed Zaher, Asmaa I. Gomaa, Mohamed Hashim, Ayat R. Abdallah, Mahmoud Moawad, and Magdy Fouad Youakim. Expression of ssx-1 and ssx-5 genes in the peripheral blood of patients with hepatocellular carcinoma. Egyptian Journal of Medical Human Genetics, 15(1):45–51, January 2014. URL: http://dx.doi.org/10.1016/j.ejmhg.2013.11.003, doi:10.1016/j.ejmhg.2013.11.003. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmhg.2013.11.003)

[5. (Güre2002The) Ali O. Güre, Isaac J. Wei, Lloyd J. Old, and Yao‐Tseng Chen. The ssx gene family: characterization of 9 complete genes. International Journal of Cancer, 101(5):448–453, September 2002. URL: http://dx.doi.org/10.1002/ijc.10634, doi:10.1002/ijc.10634. This article has 99 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.10634)

[6. (Zöllner2015Synovial) Stefan K. Zöllner, Claudia Rössig, and Jeffrey A. Toretsky. Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer. Cancer and Metastasis Reviews, 34(3):417–428, August 2015. URL: http://dx.doi.org/10.1007/s10555-015-9575-z, doi:10.1007/s10555-015-9575-z. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10555-015-9575-z)

[7. (Simpson2005Cancertestis) Andrew J. G. Simpson, Otavia L. Caballero, Achim Jungbluth, Yao-Tseng Chen, and Lloyd J. Old. Cancer/testis antigens, gametogenesis and cancer. Nature Reviews Cancer, 5(8):615–625, July 2005. URL: http://dx.doi.org/10.1038/nrc1669, doi:10.1038/nrc1669. This article has 1257 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrc1669)